Artegraft instructions for use (ifu) indications for use section states that the use of artegraft for femoropopliteal bypass should be reserved for those patients where the autologous saphenous vein is absent or inadequate.It is also not recommended for reconstruction across the knee joint.However, in the absence of other viable alternatives, the surgeon may well find the benefit to risk ratio warrants its use as an attempted limb salvage procedure.The graft involved was not received for evaluation so the issue was not able to be confirmed.Additional patient information requested, including status and condition of graft, was received 31may2023; the graft was not patent and despite limb salvage options, patient required an aka on (b)(6) 2023.The patient was reported as stable and was discharged on (b)(6) 2023 to inpatient rehab.Additional request for information was submitted 15jun2023 to clarify series of events leading to the aka.No new information was provided to date.A review of complaint data within the past three years was completed and there were no indications or trends identified that would suggest an increase in holes in grafts that have been fully processed.As 100% of the grafts are pressure tested and visually inspected prior to release, we remain inconclusive about the root cause of the issue.Based on the documentation and complaint history review, we do not believe there is a systemic issue with these devices.No further actions were determined to be necessary at this time; all product quality and clinical issues will continue to be monitored within quality assurance trending.".
|